Concord Medical Services Holdings Limited (NYSE:CCM) Sees Significant Growth in Short Interest

Concord Medical Services Holdings Limited (NYSE:CCM) saw a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 7,578 shares, a growth of 63.3% from the July 30th total of 4,641 shares. Approximately 0.3% of the shares of the stock are sold short. Based on an average daily volume of 117,289 shares, the short-interest ratio is currently 0.1 days.

Concord Medical Services Trading Down 4.2%

Concord Medical Services stock traded down $0.20 during trading hours on Monday, reaching $4.56. 25,670 shares of the company’s stock traded hands, compared to its average volume of 40,232. The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.46 and a current ratio of 0.48. Concord Medical Services has a fifty-two week low of $3.18 and a fifty-two week high of $6.98. The firm’s 50 day moving average is $4.64 and its 200-day moving average is $4.34.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CCM shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a report on Saturday, August 15th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.